by The Shigella Test Kit Market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Shigella is a contagious bacterial infection that spreads from person to person through contaminated food or water. Shigella test kits are used to detect the presence of Shigella bacteria in stool samples. Common products available in the market include ELISA test kits, rapid test kits, and PCR test kits. Rapid test kits offer the advantage of fast diagnosis within 15-30 minutes. ELISA and PCR based kits provide highly accurate results but require laboratory setup. Rising prevalence of shigellosis globally is expected to generate increased demand for diagnostic testing, driving the market growth over the forecast period.
Market Dynamics:
Growing emphasis on early detection and prevention of infectious diseases is a major driver for this market. Shigellosis can cause acute diarrhea and other long-term health complications if left untreated. Rapid diagnosis enables timely treatment and management of the disease. Increasing focus on point-of-care (POC) testing is also fueling market growth. POC tests provide rapid results at the site of patient care without the need for centralized laboratories or equipment. This allows for earlier clinical decisions and disease management. Additionally, technological advancements are leading to the development of advanced rapid kits with enhanced specificity and sensitivity. Introduction of novel molecular diagnostic solutions will further aid market expansion over the forecast period.
Segment Analysis
Shigella Test Kit Market is segmented into Immunoassay test, Conventional culture Test and Multiplex PCR. The Immunoassay test segment currently dominates the market and accounts for around 55% of the total market share. This is because Immunoassay tests provide rapid and accurate results within a shorter turnaround time as compared to conventional culture tests.
PEST Analysis
Political: Regulations regarding food safety and water quality testing across various countries are driving the demand for effective Shigella diagnostic kits.
Economic: Rising per capita healthcare expenditure in developing nations is fostering the adoption of advanced diagnostic devices for infectious diseases detection.
Social: Growing public awareness about waterborne illnesses and food poisoning is augmenting the need for reliable Shigella testing solutions.
Technological: Introduction of automated immunoassay systems and point-of-care testing devices for rapid on-site Shigella identification are boosting the market growth.
Key Takeaways
The global Shigella Test Kit market is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing food safety concerns and rising incidence of shigellosis globally. Regionally, North America captured over 30% of the total market share in 2023 led by developed healthcare infrastructure and presence of major players in the US and Canada. Asia Pacific is anticipated to be the fastest growing market for Shigella Test Kits, expanding at around 6.5% CAGR during 2023-2030 on back of increasing healthcare spending, growing middle-class population and rising awareness about waterborne diseases among consumers.
Key players operating in the Shigella Test Kit market include Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc. and Fujirebio Diagnostics Inc. These companies are investing heavily in new product launches and strategic partnerships to strengthen their market position. For instance, in April 2022, QIAGEN introduced Lyra Direct Shigella/EIEC assay which provides real-time PCR results in less than 2 hours.
Regional analysis: Asia Pacific region is expected to witness fastest growth in the Shigella Test Kit market led by countries like China, India and Indonesia. Rapidly developing healthcare infrastructure, increasing affordability, growing disease awareness and rising medical tourism are some key factors driving the Asian market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
